Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
about
Kruppel-like factor 15 is critical for vascular inflammationIL-1 receptor 2 (IL-1R2) and its role in immune regulationAspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cellsRole of interleukin-1beta in the development of malnutrition in chronic renal failure patientsImpaired lipid levels and inflammatory response in rats exposed to cadmiumHuman IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow.Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.Pro-/anti-inflammatory cytokine gene polymorphisms and chronic kidney disease: a cross-sectional studyThe atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes.Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical StudyIncreased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosisFunctional biomarkers of depression: diagnosis, treatment, and pathophysiologyEffects of intravenous glucose and lipids on innate immune cell activation in healthy, obese, and type 2 diabetic subjects.Effects of freeze-dried cranberry powder on serum lipids and inflammatory markers in lipopolysaccharide treated rats fed an atherogenic diet.Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells."Vulnerable plaques"--ticking of the time bomb.Interleukin-6 May Contribute to Mortality in Parkinson's Disease Patients: A 4-Year Prospective StudyCD1d-dependent activation of NKT cells aggravates atherosclerosis.Apolipoprotein E induces antiinflammatory phenotype in macrophagesRole of Renin-Angiotensin system and oxidative stress on vascular inflammation in insulin resistence model.Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic miceCytokines and atherosclerosis: a comprehensive review of studies in miceInterleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cellsCarotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis.An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease.VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.Acute cholecystitis and myocardial infarction: a case study with coronary involvementInterleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions.Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach.Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?EPAC proteins transduce diverse cellular actions of cAMP.Adiporedoxin suppresses endothelial activation via inhibiting MAPK and NF-κB signaling.Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.Cocoa polyphenols and inflammatory markers of cardiovascular disease.Attenuation of experimental atherosclerosis by interleukin-19.
P2860
Q24321728-14C58A1D-4606-4C47-B567-50524294AF6EQ26826872-3BDA3BFE-CB73-4A2A-ABA0-58D7409FA718Q28217990-8B9FF1EA-640C-43F4-92B0-C14CAB37481CQ28253697-BC312A9F-57D5-4EFE-9BF4-80D7B7AB5243Q28596181-DE9659F2-28DA-405A-A65E-96A9F323306FQ30438030-5D70B242-7589-4A92-8B2E-571A4C416166Q30438758-D4D6884D-CD62-4E8C-BFEC-E9D988862052Q30445485-0CBED199-1E75-4D65-AB85-C3A1734DD927Q33967700-E8DB805E-FAD3-49E9-BD68-09C01363BEB6Q34101299-C0C365D4-48E6-47BE-BD0E-DA31D73BDC23Q34122005-2C9F3CB8-BE92-4052-8687-7725DCD12481Q34740007-0219632F-7E89-48CA-A54E-F156D4E8BC71Q34978641-68A6B45A-999F-4589-B257-DE5335B52266Q34983608-13E9D0F5-E938-4CCB-B09B-894A14982C30Q35356872-3774514A-EF0D-4CE5-AE4D-15DC7F34B9E1Q35363465-CA4F7A80-8CDC-4589-93D0-DD52ED1FD845Q35566467-F9F2EFBA-3FC5-41B2-A7F0-EB1E858C6497Q35741865-0DB55C18-2944-4C79-B556-6C48991C97B0Q35968518-93CAD7D1-86FD-4887-B8D0-DBB3E305CB34Q36006272-068E684A-20EB-45BC-9B32-7AE0B61B3935Q36399122-3CC35255-8195-47D3-BF91-BF3A182E30BBQ36486217-C766618E-3304-43B8-965C-6C7CBD90464DQ36566170-20ECAA62-C5FB-401A-BF9A-7B528C89C04FQ36747201-6ED040FA-B1A0-4458-9C05-DDA365F3D5C0Q36802942-2735DA30-748C-403F-8851-1A6CE00A098DQ36835789-0862BE63-BB55-4393-A117-CB37E351AA52Q36959236-29F10B84-7E4D-447D-A7FA-D71D08A54E73Q36970340-ADC3EDAC-289C-442E-A992-31E2748D8E66Q37019592-D4912D24-8880-408A-A792-B7E4E69BED96Q37077297-C7469B71-4229-4C58-BE7C-8069B3C23823Q37111982-988080BA-4655-4166-BC7C-3F6B2CE1F1ACQ37153537-F88B49CB-9FA9-42FD-A002-79DFDC667404Q37249263-ECB07F8F-B741-4224-BEC6-FDF08A1DECFCQ37279682-5F95C162-1114-4F2F-B087-AA9A53697769Q37358225-DAE0FE74-28D5-4006-B21F-BAA9989C1204Q37390882-C5F170CB-89A5-4CE3-845E-2BCD4D538506Q37492968-F397C417-9221-4258-9C3A-C90CAC45B958Q37530905-196A19EF-1A4E-4C8B-A12A-5AE78EA61C4AQ37617758-47A636B3-4867-4A4A-AB26-5BE1D7F2072CQ37632312-6BE76BC2-970A-4E3B-9238-5C2AF0BF140E
P2860
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@ast
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@en
type
label
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@ast
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@en
prefLabel
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@ast
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@en
P2093
P356
P1476
Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
@en
P2093
Erik A L Biessen
Jan H von der Thüsen
Johan Kuiper
Theo J C van Berkel
P304
P356
10.1124/PR.55.1.5
P577
2003-03-01T00:00:00Z